Anne Wojcicki is the co-founder and CEO of 23andMe, a pioneering direct-to-consumer DNA testing firm based in Silicon Valley. 23andMe provides genetic testing for individuals curious about their ancestry and genetic make-up (they product over 150 personalised genetic reports), and is a platform for researchers looking for study participants. It has one of the world’s largest databases of individual genetic information.
A former Wall Street analyst, Anne brings over 10-year experience in healthcare investing, focusing on biotechnology companies. Disillusioned by the culture of Wall Street and its attitude towards health care, she left the investing world with the hope that she could have a positive impact on research and medicine through 23andMe.
Anne teamed up with cofounders Linda Avey and Paul Cusenza to start DNA testing company 23andMe in 2006. 23andMe got a $300 million investment from GSK, formerly GlaxoSmithKline, in July 2018; they are partnering on drug development.
The company has received around $800 million in funding from several prominent technology and health science companies, strategic angel investors, and venture capital firms: GlaxoSmithKline, Sequoia Capital, Fidelity, Euclidean Capital, Altimeter Capital and the Wallenberg Foundation. Other 23andMe investors include Yuri Milner, Johnson & Johnson, MPM Capital, The Roche Venture Fund, GV (Google Ventures), New Enterprise Associates., Casdin Capital, WuXi Healthcare Ventures, Xfund, and Illumina.
23andMe is also doing its own drug discovery and is valued at over $2 billion.
23andMe’s personal genome test kit was named Invention of the Year by Time magazine in 2008,
In 2013, The Fast Company named Anne as “The Most Daring CEO”.
Anne Wojcicki is the co-founder & CEO of 23andMe, a pioneering DNA testing firm based in Silicon Valley. It provides genetic testing for individuals curious about their ancestry and genetic make-up (they product over 150 personalised genetic reports), and is a platform for researchers looking for study participants. It has one of the world’s largest databases of individual genetic information.
The Wall Street Journal
Thorold Barker is Editor, Europe, Middle East and Africa, for The Wall Street Journal and Dow Jones Newswires overseeing the combined editorial resources of the newspaper and newswire. Mr. Barker joined the Journal in 2008 when he relaunched Heard on the Street as a global commentary and analysis product, covering business, finance and macro-economics. Before joining the Journal he worked at the Financial Times in London and New York, having begun his career at Bain & Company, a global business and strategy consulting firm.
IPM Growth | Startup Grind
London DirectorView Profile
London Co-directorView Profile
London Co-DirectorView Profile
Startup Grind AmbassadorView Profile